Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity

British Journal of Pharmacology

Volumn 127, Issue 1, 1999, Pages 195-203

  Galle, Jan ^a   Zabel, Ulrike ^a   Hübner, Ulrich ^a   Hatzelmann, Armin ^b   Wagner, Birgit ^a   Wanner, Christoph ^a   Schmidt, Harald H H W ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

Cyclic GMP; Dhosphodiesterase; Endothelium; Nitrates; Nitric oxide; Soluble guanylyl cyclase; Vasoconstriction; Vasodilation; YC 1

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1 HYDROXY 2 OXO 3,3 BIS(3 AMONOETHYL) 1 TRIAZENE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACETYLCHOLINE; CYCLIC GMP; ENZYME ACTIVATOR; GUANYLATE CYCLASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHENYLEPHRINE; PHOSPHODIESTERASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; BLOOD VESSEL TONE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVITY; KINETICS; NONHUMAN; NUCLEOTIDE METABOLISM; PRIORITY JOURNAL; RABBIT; VASCULAR RING;

ANIMALS; AORTA, THORACIC; CYCLIC GMP; ENZYME ACTIVATION; ENZYME INHIBITORS; GUANYLATE CYCLASE; INDAZOLES; ISOENZYMES; KINETICS; MUSCLE CONTRACTION; MUSCLE RELAXATION; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE DONORS; NITROPRUSSIDE; NITROSO COMPOUNDS; OXADIAZOLES; PHOSPHORIC DIESTER HYDROLASES; QUINOXALINES; RABBITS; VASODILATOR AGENTS;

EID: 0346643472     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702495     Document Type: Article

References (29)

1. Arnold, W.P., Mittal, C.K., Katsuki, S. & Murad, F. (1977). Nitric oxide activates guanylate cyclase and increases guanosine 3′,5′-monophosphate levels in various tissue preparations. Proc. Natl. Acad. Sci. U.S.A., 74, 3203-3207.
2. Bauer, A.C. & Schwabe, U. (1980). An improved assay or cyclic 3′,5′-nucleotide phosphodiesterase with QAE sephadex A-25. Naunyn-Schmiedeberg's Arch. Pharmaracol., 311, 193-198.
3. Beckman, J.S., Chen, J., Ischiropoulos, H. & Crow, J.P. (1994). Oxidative chemistry of peroxynitrite. Meth. Enzymol., 233, 229-240.
4. Beckman, J.S., Ye, Y.Z., Anderson, P.G., Chen, J., Accavitti, M.A., Tarpey, M.M. & White, C.R. (1994). Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol Chem. Hoppe-Seyler, 375, 81-88.
5. Böhme, E., Graf, H. & Schultz, G. (1978). Effects of sodium nitroprusside and other smooth muscle relaxants on cyclic GMP formation in smooth muscle and platelets. Adv. Cyclic Nucleotide Res., 9, 131-143.
6. Busse, R. & Mülsch, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Letters, 275, 87-90.
7. Dent, G. & Rabe, K.F. (1996). Effects of theophylline and nonselective xanthine derivatives on PDE isoenzymes and cellular function. In Phosphodiesterase inhibitors. ed Schudt, C., Dent, G. & Rabe, K.F. pp. 41-64. London, UK: Academic Press.
8. Friebe, A., Schultz, G. & Koesling, D. (1996). Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J., 15, 6863-6868.
9. Galle, J., Bengen, J., Schollmeyer, P. & Wanner, C. (1995a). Impairment of endothelium-dependent dilation in rabbit renal arteries by oxidized lipoprotein(a). Circulation, 92, 1582-1589.
10. Galle, J., Schini, V., Stuntz, P. & Schollmeyer, P. (1995b). Interleukin-1β induces the formation of nitric oxide in isolated juxtaglomerular cells: Influence on renin secretion. Nephrol. Dial. Transplant., 10, 191-197.
11. Garthwaite, J., Southam, E., Boulton, C., Nielsen, E., Schmidt, K & Mayer, B. (1995). Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one. Molecular Pharmacology, 48, 184-188.
12. 2+-transport ATPase and brain phosphodiesterase by activators and inhibitors. Biochem. J., 207, 541-548.
13. Gillespie, J.S., Liu, X. & Martin, W. (1989). The effects of L-arginine and Ng-monomethyl L-arginine on the response of the rat anococcygeus to NANC nerve stimulation. Br. J. Pharmacol., 98, 1080-1082.
14. Ko, F.N., Wu, C.C., Kuo, S.C., Lee, F.Y. & Teng, C.M. (1994). YC-1, a novel activator of platelet guanylate cyclase. Blood, 84, 4226-4233.
15. Lowry, O.H., Rosebrough, N.J., Farr, A L. & Randall, R.J. (1951). Protein measurement with phenol reagent. J. Biol. Chem., 193, 265-275.
16. Moncada, S. & Higgs, E.A. (1991). Endogenous nitric oxide: Physiology, pathology and clinical relevance. Eur. J. Clin. Invest., 21, 361-374.
17. Mülsch, A., Bauersachs, J., Schäfer, A., Stasch, J.-P., Kast, R. & Busse, R. (1997). Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br. J. Pharmacol, 120, 681-689.
18. Münzel, T., Sayegh, H., Freeman, B.A., Tarpey, M.M. & Harrtson, D.G. (1995). Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance. J. Clin. Invest., 95, 187-194.
19. Schmidt, H.H.H.W., Lohmann, S.L. & Walter, U. (1993). The nitric oxide and cGMP signal-transduction pathway. Biochem. Biophys. Acta, 1178, 153-175.
20. Schmidt, H.H.H.W. & Walter, U. (1994). NO at work. Cell, 78, 919-925.
21. i. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 682-690.
22. Schudt, C., Winder, S., Müller, B. & Ukena, D. (1991b). Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem. Pharmacol., 42, 153-162.
23. Stamler, J.S. (1994). Redox signalling: nitrosylation and related interactions of nitric oxide. Cell, 78, 931-936.
24. Thompson, W.J., Terasaki, W.L., Epstein, P.M. & Strada, S.J. (1979). Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv. Cycl. Nucl. Res., 10, 69-92.
25. Wegener, J.W., Gath, I., Förstermann, U. & Nawrath, H. (1997). Activation of soluble guanylyl cyclase by YC-1 in aortic smooth muscle but not in ventricular myocardium from rat. Brit. J. Pharmacol., 122, 1523-1529.
26. Wu, C.C., Ko, F.N., Kuo, S.C., Lee, F.Y. & Teng, CM. (1995). YC-1 inhibited human platelet aggregatiaon through NO-independent activation of soluble guanylate cyclase. Br. J. Pharmacol., 116, 1973-1978.
27. Wu, C.C., Ko, F.N. & Teng, C.M. (1997). Inhibition of platelet adhesion to collagen by cGMP-elevating agents. Biochem. Biophys. Res. Commun., 231, 412-416.
28. Yu, S.M., Cheng, Z.J., Gug, J.H., Lee, F.Y. & Kuo, S.C. (1995). Mechanism of antiproliferation caused by YC-1, an im indazole derivative, in cultured rat A10 vascular smooth-muscle cells. Biochem. J., 306, 787-792.
29. Zelis, R. & Mason, D.T. (1975). Isosorbide dinitrate. Effect on the vasodilator response to nitroglycerin. J.A.M.A., 234, 166-170.